A new analysis provides further insight into factors affecting plaque stability and subsequent ischemic events

The product's updated indications include quantification and long-term monitoring of amyloid plaques on imaging.

Although gadopiclenol is approved for adults and children ages 2 and older, there is limited data on its use in the pediatric population. 

The agent “exhibits powerful tumor delineation” in challenging cases of determining cancer subtypes, and could potentially lead to more personalized, effective treatment strategies. 

A new analysis details the prevalence of interpretation errors in EDs, the factors that influence them and how they affect patient care. 

The healthcare sector will suffer the most if the federal Medicaid cuts proposed in Congress are enacted, the Commonwealth Fund said. According to the group’s analysis, hospitals, nursing homes, and clinics could be forced to shut their doors.

OSU Medical Center has addressed common challenges including insufficient documentation, miscommunication, and the risk of repeat imaging. 

Federal lawmakers have a fresh resource to keep them up on healthcare AI that falls outside of formal FDA oversight. It comes in the form of a new report from the nonprofit Bipartisan Policy Center.

Ticagrelor, an antiplatelet medication from AstraZeneca commonly prescribed by cardiologists, gained FDA approval back in 2011. The author of a new investigative report, however, is raising several concerns about the data used to secure that approval.